Under construction – not a live service
Sign in
Taking people in AustraliaNo phase

Dedicated Care for Women With Inflammatory Bowel Disease During Pregnancy, Including a Virtual Option

Tests specialist team care, including a virtual option, for pregnant women with inflammatory bowel disease.

Plain-language title generated from the registry record
Registry title: Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study

Key facts

Where
Hobart, Melbourne, and Sydney, AustraliaSee the 7 sites

Where in Australia

  • Royal Hobart HospitalHobart, AustraliaNot yet recruiting
  • Austin HealthMelbourne, AustraliaTaking people
  • Eastern HealthMelbourne, AustraliaTaking people
  • Mercy HealthMelbourne, AustraliaTaking people
  • Peninsula HealthMelbourne, AustraliaNot yet recruiting
  • Royal Prince Alfred HospitalSydney, AustraliaTaking people
  • St Vincent's Hospital DarlinghurstSydney, AustraliaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Austin Health
Trial code
NCT07916727
Record updated
4 November 2026
Original description
IBD pregnancy requires multidisciplinary management, but access to this may be difficult for some, resulting in variation in care which may in turn impair quality of healthcare delivery. We need to devise innovative ways to deliver care to overcome these barriers. The PREGO study will interrogate the value of multidisciplinary care in IBD pregnancy, and test a new virtual-based way of improving access to care.Read full original descriptionShow less

Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study

IBD pregnancy requires multidisciplinary management, but access to this may be difficult for some, resulting in variation in care which may in turn impair quality of healthcare delivery. We need to devise innovative ways to deliver care to overcome these barriers. The PREGO study will interrogate the value of multidisciplinary care in IBD pregnancy, and test a new virtual-based way of improving access to care.

Inclusion: Biologically female adult patients (aged 18 years or older) with a diagnosis of inflammatory bowel disease (IBD) receiving care for their IBD during pregnancy.

Exclusion: Pregnant patients with inflammatory bowel disease receiving dedicated IBD pregnancy care at an alternative tertiary institution; Non-pregnant inflammatory bowel disease patients; Age <18; Non-consenting patients.

ClinicalTrials.gov NCT07916727